pSvida to list on Nasdaq
Tuesday, 10 June, 2008
WA-based biotech pSvida (ASX: PSD) is to reincorporate onto the Nasdaq, the American stock exchange.
The re-incorporation plan was first mooted in April. At a shareholders' meeting today, 94 per cent of shareholders, 192 in total, voted for the resolution, while six voted against it.
Between them the 192 shareholders hold around 96 per cent of the voting power.
The shareholders also voted to adopt a new employee incentive plan.
$780m Sydney Biomedical Accelerator gains its founding Executive Director
Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...
Portable point-of-care test detects four common STIs in under an hour
Australian researchers have developed a portable point-of-care test that detects four common...
AusBiotech and Proto Axiom partner on investor-focused life sciences programs
AusBiotech and Proto Axiom have announced a partnership to strengthen national coordination...
